FLR
55
6
GWW
62
4
AMP
55
-6
EQIX
67
2
GOOGL
66
2
VLO
38
5
NAVI
44
11
MET
53
2
WFC
63
-2
TMO
64
8
NVDA
55
3
HD
31
3
DE
35
-3
A
44
4
PWR
71
3
KMB
50
8
MUR
52
2
PH
74
4
IR
79
7
SRE
54
-2
FLR
55
6
GWW
62
4
AMP
55
-6
EQIX
67
2
GOOGL
66
2
VLO
38
5
NAVI
44
11
MET
53
2
WFC
63
-2
TMO
64
8
NVDA
55
3
HD
31
3
DE
35
-3
A
44
4
PWR
71
3
KMB
50
8
MUR
52
2
PH
74
4
IR
79
7
SRE
54
-2
Financhill
Back

Vertex Pharmaceuticals Quote, Financials, Valuation and Earnings

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge
Buy
62

VRTX
Vertex Pharmaceuticals

Last Price:
404.59
Seasonality Move:
11.79%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Vertex Pharmaceuticals Price Quote

$404.59
-0.02 (1.18%)
(Updated: April 24, 2024 at 5:41 AM ET)

Vertex Pharmaceuticals Key Stats

Buy
62
Vertex Pharmaceuticals (VRTX) is a Buy
Day range:
$403.47 - $406.86
52-week range:
$316.43 - $448.40
Dividend yield:
0%
P/E ratio:
29.13
P/S ratio:
10.68
P/B ratio:
5.94%
Volume:
824.2K
Avg. volume:
964.1K
1-year change:
22.21%
Market cap:
$104.5B
Revenue:
$9.9B
EPS:
$13.89

How Much Does Vertex Pharmaceuticals Make?

Is Vertex Pharmaceuticals Growing As A Company?

Vertex Pharmaceuticals Stock Price Performance

What Is Vertex Pharmaceuticals 52-Week High & Low?

Vertex Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Vertex Pharmaceuticals?

Is Vertex Pharmaceuticals Cash Flow Positive?

  • What Is VRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $3.5B
  • What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$562.2M
  • What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.1B

Vertex Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRTX return on invested capital is 23.23%
  • What Is Vertex Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 17.76%
  • What Is VRTX Return On Equity?
    ROE is a measure of profitability and is 23.23%

Vertex Pharmaceuticals Earnings Date & Stock Price

Vertex Pharmaceuticals Competitors

Vertex Pharmaceuticals Dividend Yield

Data Unavailable

Vertex Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 17.78% 2.78%
Revenue: 9.34% 0.12%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 10
Sell Recommendations: 2
Price Target: 460.34
Upside from Last Price: 13.77%

Major Shareholders

  • How many VRTX shares are owned by institutional investors?
    418.2M VRTX shares are owned by institutional investors
  • How many VRTX shares are owned by insiders?
    2.5M VRTX shares are owned by insiders